For unclear reasons, people receiving chemotherapy for solid tumors are at particularly increased risk for deep venous thrombosis and pulmonary embolism (DVT/PE).
For your security, we need to re-authenticate you.
Click the link we sent to , or click here to sign in.
Share this post
Semuloparin (a new LMWH) reduced DVT & PE in…
Share this post
For unclear reasons, people receiving chemotherapy for solid tumors are at particularly increased risk for deep venous thrombosis and pulmonary embolism (DVT/PE).